Source: prnewswire.com

Genentech acquired Regor Pharmaceuticals's Next-Generation CDK Inhibitors for $850M

Read full article »

Genentech's Competitors | Genentech's News | Genentech's Financials

Followers on Owler

26,738

Est. Annual Revenue

$10-50B

Est. Employees

10-50K

CEO

Ashley Magargee

CEO Approval Rating

75/100

Genentech is a California-based biotechnology firm that develops and commercializes medicines for the treatment of diseases such as cancer and cardiovascular.